Observational Study of BIS in Hemodialysis Patients
Public ClinicalTrials.gov record NCT05381961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Observational Study of Bioimpedance Spectroscopy (BIS) for Use in a Renal Population
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis.
Study identification
- NCT ID
- NCT05381961
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 70 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2022
- Primary completion
- Nov 7, 2022
- Completion
- Aug 31, 2023
- Last update posted
- Sep 27, 2023
2022 – 2023
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Balboa Research - Kearny Mesa | San Diego | California | 92111 | — |
| Balboa Research - Rancho Bernardo | San Diego | California | 92127 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Kidney Failure, Chronic trials
Other public records listing Kidney Failure, Chronic. Sorted by last update posted; newest first. Not a recommendation.
- NCT07426380: A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function Active, not recruiting
- NCT07763418: A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function Not yet recruiting
- NCT07446296: Kidney Transplant Improvement Through New Exercise Training to Increase Capacity Recruiting
- NCT01893710: International (Pediatric) Peritoneal Biobank Recruiting
- NCT04128189: Shingrix in Renal Transplant Recipients Recruiting
- NCT06217302: Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05381961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2023 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05381961 live on ClinicalTrials.gov.